130 related articles for article (PubMed ID: 1735954)
1. Neuroendocrine differentiation in adrenocortical carcinoma. New immunohistochemical findings supported by electron microscopy.
Miettinen M
Lab Invest; 1992 Feb; 66(2):169-74. PubMed ID: 1735954
[TBL] [Abstract][Full Text] [Related]
2. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors.
Komminoth P; Roth J; Schröder S; Saremaslani P; Heitz PU
Lab Invest; 1995 Apr; 72(4):424-31. PubMed ID: 7723281
[TBL] [Abstract][Full Text] [Related]
3. [Adrenocortical tumors with neuroendocrine differentiation].
Kazantseva IA; Poliakova GA; Gurevich LG; Morozov IA; Bezuglova TV; Smirnov VB
Arkh Patol; 2002; 64(5):8-13. PubMed ID: 12575533
[TBL] [Abstract][Full Text] [Related]
4. Synaptophysin and neurofilament proteins as markers for neuroendocrine tumors.
Miettinen M
Arch Pathol Lab Med; 1987 Sep; 111(9):813-8. PubMed ID: 2820344
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of neuroendocrine markers and epithelial cytoskeletal proteins in bronchopulmonary neuroendocrine neoplasms.
Blobel GA; Gould VE; Moll R; Lee I; Huszar M; Geiger B; Franke WW
Lab Invest; 1985 Jan; 52(1):39-51. PubMed ID: 2981372
[TBL] [Abstract][Full Text] [Related]
6. Oncocytic adrenocortical carcinomas: a pathological and immunohistochemical study of four cases in comparison with conventional adrenocortical carcinomas.
Song SY; Park S; Kim SR; Suh YL
Pathol Int; 2004 Aug; 54(8):603-10. PubMed ID: 15260851
[TBL] [Abstract][Full Text] [Related]
7. The alpha subunit of inhibin in adrenal cortical neoplasia.
Pelkey TJ; Frierson HF; Mills SE; Stoler MH
Mod Pathol; 1998 Jun; 11(6):516-24. PubMed ID: 9647588
[TBL] [Abstract][Full Text] [Related]
8. Paragangliomas of the head and neck: immunohistochemical neuroendocrine and intermediate filament typing.
Johnson TL; Zarbo RJ; Lloyd RV; Crissman JD
Mod Pathol; 1988 May; 1(3):216-23. PubMed ID: 2467285
[TBL] [Abstract][Full Text] [Related]
9. Primitive neuroectodermal tumors of the central nervous system. Patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteins.
Gould VE; Jansson DS; Molenaar WM; Rorke LB; Trojanowski JQ; Lee VM; Packer RJ; Franke WW
Lab Invest; 1990 Apr; 62(4):498-509. PubMed ID: 2159086
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
Krajewski S; Chatten J; Hanada M; Reed JC
Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
[TBL] [Abstract][Full Text] [Related]
11. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
[TBL] [Abstract][Full Text] [Related]
12. Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma.
Wick MR; Cherwitz DL; McGlennen RC; Dehner LP
Am J Pathol; 1986 Feb; 122(2):343-52. PubMed ID: 2418689
[TBL] [Abstract][Full Text] [Related]
13. Endocrine and tumor differentiation markers in poorly differentiated small-cell carcinoids of the cervix and vagina.
Ulich TR; Liao SY; Layfield L; Romansky S; Cheng L; Lewin KJ
Arch Pathol Lab Med; 1986 Nov; 110(11):1054-7. PubMed ID: 3022670
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine differentiation in carcinomas of the breast: a study of 51 cases.
Papotti M; Macrì L; Finzi G; Capella C; Eusebi V; Bussolati G
Semin Diagn Pathol; 1989 May; 6(2):174-88. PubMed ID: 2503862
[TBL] [Abstract][Full Text] [Related]
16. Selective expression of trophoblastic hormones by lung carcinoma: neurendocrine tumors exclusively produce human chorionic gonadotropin alpha-subunit (hCGalpha).
Dirnhofer S; Freund M; Rogatsch H; Krabichler S; Berger P
Hum Pathol; 2000 Aug; 31(8):966-72. PubMed ID: 10987258
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine differentiation of adrenocortical tumors.
Haak HR; Fleuren GJ
Cancer; 1995 Feb; 75(3):860-4. PubMed ID: 7828138
[TBL] [Abstract][Full Text] [Related]
18. Immunofluorescence microscopic evaluation of the intermediate filament expression of the adrenal cortex and medulla and their tumors.
Miettinen M; Lehto VP; Virtanen I
Am J Pathol; 1985 Mar; 118(3):360-6. PubMed ID: 3883796
[TBL] [Abstract][Full Text] [Related]
19. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
[TBL] [Abstract][Full Text] [Related]
20. Nestin as a marker in the classification of adrenocortical tumors.
Lachenmayer A; Lichtenauer UD; Cox T; Schott M; Malendowicz LK; Goretzki PE; Cupisti K; Scherbaum WA; Bornstein SR; Willenberg HS
Horm Metab Res; 2009 May; 41(5):397-401. PubMed ID: 19294612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
